PTLF Stock Chart & Stats
<$0.01
<$0.01(100.00%)
At close: 4:00 PM EDT
<$0.01
<$0.01(100.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume5.00K
Average Volume (3M)N/A
Market Cap
$22.21K
Enterprise Value$682.60K
Total Cash (Recent Filing)$7.86K
Total Debt (Recent Filing)$801.65K
Price to Earnings (P/E)―
Beta9.89
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding222,120,650
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)>-0.01
Price to Sales (P/S)0.00
P/FCF Ratio-0.06
Enterprise Value/Market Cap30.73
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PTLF FAQ
What was Petlife Pharmaceuticals Inc’s price range in the past 12 months?
Petlife Pharmaceuticals Inc lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Petlife Pharmaceuticals Inc’s market cap?
Petlife Pharmaceuticals Inc’s market cap is $22.21K.
When is Petlife Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Petlife Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Petlife Pharmaceuticals Inc overvalued?
According to Wall Street analysts Petlife Pharmaceuticals Inc’s price is currently Overvalued.
Does Petlife Pharmaceuticals Inc pay dividends?
Petlife Pharmaceuticals Inc does not currently pay dividends.
What is Petlife Pharmaceuticals Inc’s EPS estimate?
Petlife Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Petlife Pharmaceuticals Inc have?
Petlife Pharmaceuticals Inc has 222,120,650 shares outstanding.
What happened to Petlife Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Petlife Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in PTLF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Petlife Pharmaceuticals Inc
Based in Los Angeles, California, Petlife Pharmaceuticals, Inc. is dedicated to the discovery, formulation, commercialization, and ongoing support of both medicinal drugs and nutritional supplements for pets. Their primary focus is on addressing canine and feline cancer and various autoimmune conditions, such as arthritis, within the United States market. The company's leading product is Vitalzul, which functions by obstructing the formation of new blood vessels crucial for the growth of solid tumors. Petlife is also progressing the development of Vitalzul into a potent, prescription-only oral medication, as well as a highly concentrated version for direct intravenous or injectable application to tumors. Additionally, their offerings extend to developing palatable treats suitable for dogs and cats.